MT2017-45

· Masonic Cancer Center, University of Minnesota

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT2017-45, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: MT2017-45: CAR-T Cell Therapy for Heme Malignancies [Phase 2]